Results 1 to 10 of about 732,366 (171)

4-Year Follow-Up after Transatrial Transcatheter Tricuspid Valve Replacement with the LuX-Valve

Journal of Cardiovascular Development and Disease, 2022
Tricuspid regurgitation (TR) has become one of the most common valve diseases. Patients with severe TR are often at high surgical mortality risk. Transcatheter tricuspid valve interventions have emerged as a promising alternative to open-heart surgery ...
Xiaoping Ning, Jingyi Cao, Wei Wang, Guangwei Zhou, Fan Yang, Zhiyun Xu, Lin Han, Fan Qiao, Fanglin Lu   +8 more
doaj   +4 more sources

Transcatheter tricuspid valve replacement: will it prevail? [PDF]

Frontiers in Cardiovascular Medicine
Severe tricuspid regurgitation (TR) is a prevalent and challenging condition associated with poor survival outcomes and significant morbidity. Medical therapy alone often fails to provide adequate symptom relief, and stand-alone surgical intervention is ...
Xiling Zhang, Xiling Zhang, Nina Sophie Pommert, Nina Sophie Pommert, David Meier, Stephanie L. Sellers, Stephanie L. Sellers, Stephanie L. Sellers, Hatim Seoudy, Hatim Seoudy, Oliver J. Müller, Oliver J. Müller, Derk Frank, Derk Frank, Tim Attmann, Tim Attmann, Rouven Berndt, Gregor Warnecke, Gregor Warnecke, Thomas Puehler, Thomas Puehler, Georg Lutter, Georg Lutter   +22 more
doaj   +3 more sources

Update on Transcatheter Tricuspid Valve Replacement Therapies

Frontiers in Cardiovascular Medicine, 2021
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg, Edwin Ho, Mei Chau, Azeem Latib   +3 more
doaj   +3 more sources

Transcatheter Double Valve Replacement to Treat Aortic Stenosis and Severe Tricuspid Regurgitation with 3D Printing Guidance after Mechanical Mitral Valve Replacement

Journal of Cardiovascular Development and Disease, 2022
Background: Transcatheter treatments of tricuspid regurgitation (TR) have been emerging as alternatives for high-risk patients. In contrast to the immobilization of the common transcatheter tricuspid device, using a radial force-independent stent valve ...
Mengen Zhai, Yu Mao, Yanyan Ma, Yang Liu, Jian Yang   +4 more
doaj   +2 more sources

Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up

Frontiers in Cardiovascular Medicine, 2023
Generally, the dysfunction or failure of bioprosthetic heart valves (BHVs) is managed by replacement surgery. In the case of tricuspid valve dysfunction, re-do surgery is rarely attempted because of the critically high risk of developing pulmonary ...
Abdurashid Mussayev, Serik Alimbayev, Nursultan Tanaliev, Aidyn Kuanyshbek, Aripov Marat, Timur Lesbekov, Yerkezhan Raissov, Aigerim Sadykova, Askarovna Kenzhebayeva Kamila, Murat Mukarov, Yuriy Pya   +10 more
doaj   +1 more source

Transcatheter Tricuspid Valve Replacement: Case Selection, Technical Considerations, and Procedural Planning

US Cardiology Review, 2023
Tricuspid regurgitation (TR) is a highly prevalent valve disorder in the US, with prevalence increasing with age. Without treatment, severe TR carries a poor prognosis.
Muhammad Asim Shabbir, Pradeep Yadav, Nidhish Tiwari, Poonam Velagapudi   +3 more
doaj   +1 more source

Current Status and Challenges of Valvular Heart Disease Interventional Therapy

Cardiology Discovery, 2022
. Valvular heart disease (VHD) is common in the global population, occupying an heavy disease burden among aging population. Currently, it is the booming era of transcatheter VHD treatment, even with superiority than traditional open heart surgery in ...
Yi Zhang, Tianyuan Xiong, Yuan Feng, Tianyu Xu, Xaoxia Fu   +4 more
doaj   +1 more source

Tricuspid Stenosis in Pregnancy

JACC: Case Reports, 2020
Redo tricuspid valve replacement has high surgical operative mortality. Transcatheter valve-in-valve provides a viable option for valve replacement. We discuss the decision-making process involved in performing transcatheter tricuspid valve-in-valve ...
Oluwayemisi L. Adejumo, MD, Irbaz Hameed, MD, Tracy Grossman, MD, Inna Landres, MD, Christopher Tam, MD, Jonathan Villena-Vargas, MD, Shanna Sykes Hill, MD, Dmitriy N. Feldman, MD, Robert M. Minutello, Luke Kim, Geoffrey Bergman, MD, Shing-Chiu Wong, MD, Arash Salemi, MD, Harsimran S. Singh, MD, MSc   +13 more
doaj   +1 more source

Transcatheter tricuspid valve interventions: Current status and future perspectives

Frontiers in Cardiovascular Medicine, 2022
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi, Alberto Alperi, Marcel Almendárez, Marcel Almendárez, Rut Álvarez, Rut Álvarez, Cesar Moris, Cesar Moris, Cesar Moris, Victor Leon, Victor Leon, Iria Silva, Iria Silva, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Isaac Pascual, Isaac Pascual, Isaac Pascual, Pablo Avanzas, Pablo Avanzas, Pablo Avanzas   +21 more
doaj   +1 more source

Rediscovered and Unforgotten: Transcatheter Interventions for the Treatment of Severe Tricuspid Valve Regurgitation

US Cardiology Review, 2021
Tricuspid valve regurgitation is both globally prevalent and undertreated. Historically, surgical intervention for isolated tricuspid regurgitation (TR) was avoided despite the prevalence of TR, largely due to poor surgical outcomes and an incomplete ...
Kusha Rahgozar, Sharon Bruoha, Edwin Ho, Ythan Goldberg, Mei Chau, Azeem Latib   +5 more
doaj   +1 more source